3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
139
Carcinoma, Intraductal, Noninfiltrating
8
Neoplasm Metastasis
6
Breast Carcinoma In Situ
5
Breast Neoplasms, Male
4
Breast Diseases
4
Arthralgia
4
Triple Negative Breast Neoplasms
3
Ovarian Neoplasms
3
Endometrial Neoplasms
3
Advanced Breast Cancer
3
Neoplasms
2
Breast Cancer Metastatic
2
Solid Tumor
1
Sexual Dysfunctions, Psychological
1
Sexual Dysfunction, Physiological
1
Seizures
1
Sarcoma
1
Recurrence
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Pain
1
Osteoporosis
1
Obesity
1
Muscle Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Locoregional Recurrence
1
Invasive Breast Cancer
1
Hypogonadism
1
Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer
1
Interventions
Morphine
6
Surveys and Questionnaires
5
Ketamine
4
Sodium Chloride
3
Saline Solution
3
Lidocaine
3
Educational Status
3
Dexmedetomidine
3
Cognitive Behavioral Therapy
3
Anesthetics, Local
3
Pregabalin
2
Mindfulness-Based Stress Reduction
2
Hypnosis
2
Fentanyl
2
Bupivacaine
2
Botulinum Toxins, Type A
2
Acetaminophen
2
ziconotide
1
tianeptine
1
siltuximab
1
onabotulinum toxin A
1
erenumab
1
Yoga
1
Waiting Lists
1
Transcutaneous Electric Nerve Stimulation
1
Tramadol
1
Therapeutics
1
Telemedicine
1
Tea
1
Tamoxifen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Chronic Pain
×
Anastrozole
×
Clear all
NCT06154590
2023-12-04
NASBP-B-09
Paradyne Networks A Foundation
Not yet recruiting
100 enrolled